awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38848273-09722218-E47C-4461-8760-99F617438E88
Q38848273-09722218-E47C-4461-8760-99F617438E88
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38848273-09722218-E47C-4461-8760-99F617438E88
Contemporary insights into the pathogenesis and treatment of chronic myeloproliferative neoplasms.
P2860
Q38848273-09722218-E47C-4461-8760-99F617438E88
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38848273-09722218-E47C-4461-8760-99F617438E88
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
710f71cbc5556c5b6131961c9b9f6cfa04aa6f35
P2860
CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms.